De novo and apparent de novo hepatitis B virus infection after liver transplantation

Journal of Hepatology

Volumn 26, Issue 3, 1997, Pages 517-526

  Roche, Bruno ^a   Samuel, Didier ^a   Gigou, Michele ^a   Feray, Cyrille ^a   Virot, Veronique ^a   Schmets, Laurent ^a   David, Marie Françoise ^a   Arulnaden, Jean Louis ^a   Bismuth, Alain ^a   Reynes, Michel ^a   Bismuth, Henri ^a  

^a HÔPITAL PAUL BROUSSE   (France)

Author keywords

hepatitis B; liver transplantation

Indexed keywords

DNA;

ADULT; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; DNA SEQUENCE; DONOR; FEMALE; HEPATITIS B; HISTOPATHOLOGY; HUMAN; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; PRIORITY JOURNAL; SURVIVAL; VIRUS INFECTION;

EID: 0031047577     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(97)80416-3     Document Type: Article

References (32)

1. Todo S, Demetris AJ, Van Thiel D, Teperman L, Fung JJ, Starzl TE. Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology. 13:1991;619-626.
2. O'Grady JG, Smith HM, Davies S, Daniels HM, Donaldson PT, Tan KC, Portmann B, Alexander GJM, Williams R. Hepatitis B virus reinfection after liver transplantation: serological and clinical implications. J Hepatol. 14:1992;104-111.
3. Douglas DD, Rakela J, Taswell HF, Krom RAF, Wiesner RH. Hepatitis B virus replication patterns after orthotopic liver transplantation: de novo versus recurrent infection. Transplant Proc. 25:1993;1755-1757.
4. Chazouillères O, Mamish D, Kim M, Carey K, Ferrell L, Roberts JP, Ascher NL, Wright TL. "Occult" hepatitis B virus source of infection in liver transplant recipients. Lancet. 343:1994;142-146.
5. Gugenheim J, Samuel D, Saliba F, Castaing D, Bismuth H. Use of flexible triple drug immunosuppressive therapy in liver transplantation. Transplant Proc. 19:1987;3805-3807.
6. Scotto J, Hadchouel M, Hery C, Yvart J, Tiollais P, Brechot C. Detection of hepatitis B virus DNA in serum by a single spot hybridization technique: comparison with results of other viral markers. Hepatology. 3:1983;279-284.
7. Feray C, Zignego AL, Samuel D, Bismuth A, Reynes M, Tiollais P, Bismuth H, Brechot C. Persistent hepatitis B virus infection of mononuclear cells without concomitaent liver infection: transplantation model. Transplantation. 49:1990;1155-1158.
8. Crisan D, Cadoff E, Mattson JC, Hartle KA. Polymerase chain reaction: amplification of DNA from fixed tissue. Clin Biochem. 23:1990;489-495.
9. Greer CE, Peterson SL, Kiviat NB, Manos MM. PCR amplification from paraffin embedded tissues. Am J Clin Pathol. 95:1991;117-124.
10. Samuel D, Bismuth A, Mathieu D, Arulnaden JL, Reynes M, Benhamou JP, Brechot C, Bismuth H. Passive immunoprophylaxis after liver transplantation in HBsAg positive patients. Lancet. 337:1991;813-815.
11. Hoofnagle JH, Seeff LB, Balez ZB, Zimmerman HJ. Type B hepatitis after transfusion with blood containing antibody to hepatitis B core antigen. N Engl J Med. 298:1978;1379-1383.
12. Donovan JP, Schafer DF, Goonewardene T, Sorell MF, McCashland TM, Zetterman RK, Langnas AN, Heffron TG, Fox J, Shaw BW. Development of hepatitis B infection after liver transplantation with donor livers from patients with HBc Ab and HBs Ab. Hepatology. 20:1994;A130. part 2.
13. Lei D, Wu J, Sullivan DE, Dash S, Gerber MA. Detection of hepatitis B virus sequences in liver tissues of seronegative organ donors. Int Hepatol Commun. 3:1995;154-160.
14. Wachs ME, Amend WJ, Ascher NL, Bretan PN, Emond J, Lake JR, Melzer JS, Roberts JP, Tomlanovich SJ, Vincenti F, Stock P. The risk of transmission of hepatitis B from HBsAg (-), HBcAb (+), HBcIgM (-) organ donors. Transplantation. 59:1995;230-234.
15. Lowell JA, Howard TK, White HM, Shenoy S, Huettner PC, Brennan DC, Peters MG. Serological evidence of past hepatitis B infection in liver donor and hepatitis B infection in liver allograft. Lancet. 345:1995;1084-1085.
16. Radomski JS, Moritz MJ, Armenti VT, Munoz S, Smolinski S. Risk of hepatitis B transmission from organ donors who are hepatitis B surface antigen (-) and hepatitis B core antibody (+). Hepatology. 20:1994;A129. part 2.
17. Fong TL, Di Bisceglie AM, Gerber MA, Waggoner JG, Hoofnagle JH. Persistence of hepatitis B virus DNA in the liver after loss of HBsAg in chronic hepatitis B. Hepatology. 18:1993;1313-1318.
18. Mason A, Yoffe B, Noonan C, Mearns M, Campbell C, Kelley A, Perrillo RP. Hepatitis B virus DNA in peripheral blood mononuclear cells in chronic hepatitis B after HBsAg clearance. Hepatology. 16:1992;36-41.
19. Marcellin P, Martinot-Peignoux M, Loriot MA, Giostra E, Boyer N, Thiers V, Benhamou JP. Persistence of hepatitis B virus DNA demonstrated by polymerase chain reaction in serum and liver after loss of HBsAg induced by antiviral therapy. Ann Intern Med. 112:1990;227-228.
20. Marcellin P, Giostra E, Martinot-Peignoux M, Loriot MA, Jaegle ML, Wolf P, Degott C, Degos F, Benhamou JP. Redevelopment of hepatitis B surface antigen after renal transplantation. Gastroenterology. 100:1991;1432-1434.
21. Degos F, Lugassy C, Degott C, Debure A, Carnot F, Thiers V, Tiollais P, Kreis H, Brechot C. Hepatitis B virus and hepatitis B-related viral infection in renal transplant recipients. Gastroenterology. 94:1988;151-156.
22. Liang TJ, Baruch Y, Ben-Porath E, Enat R, Bassan L, Brown NV, Rimon N, Blum HE, Wands JR. Hepatitis B virus infection in patients with idiopathic liver disease. Hepatology. 13:1991;1044-1051.
23. Thiers V, Kremsdorf D, Schellekens H, Goudeau A, Srinsky J, Nakajima E, Mack D, Driss F, Wands J, Tiollais P, Brechot C. Transmission of hepatitis from hepatitis B seronegative subjects. Lancet. ii:1988;1273-1276.
24. Pasquinelli C, Lauré F, Chatenoud L, Beaurin G, Gazengel C, Bismuth H, Degos F, Tiollais P, Bach JF, Brechot C. Hepatitis B virus DNA in mononuclear blood cells. J Hepatol. 3:1986;95-103.
25. Brechot C, Degos F, Lugassy C, Thiers V, Zafrani S, Franco D, Bismuth H, Trepo C, Benhamou JP, Wands J, Isselbacher K, Tiollais P, Berthelot P. Hepatitis B virus DNA in patients with chronic liver disease and negative tests for hepatitis B surface antigen. N Engl J Med. 312:1985;270-276.
26. Cadranel JF, Grippon P, Lunel F, Desruennes M, Leger P, Azar N, Moussalli J, Pauwels A, Cabrol A, Salmon P, Le Charpentier Y, Cabrol C, Huraux JM, Opolon P. Chronic liver dysfunction in heart transplant recipients, with special reference to viral B, C and non-A, non-B, non-C hepatitis. Transplantation. 52:1991;645-650.
27. Locasciulli A, Bacigalupo A, Van Lint MT, Chemello L, Pontisso P, Occhini D, Uderzo C, Shulman HM, Portmann B, Marmont AM, Alberti A. Hepatitis B virus infection and liver disease after allogeneic bone marrow transplantation: a report of 30 cases. Bone Marrow Transplant 90; 6: 25-9.
28. Feray C, Gigou M, Samuel D, Reyes G, Bernuau J, Reynes M, Bimuth H, Brechot C. Hepatitis C virus RNA and hepatitis B virus DNA in serum and liver of patients with fulminant hepatitis. Gastroenterology. 104:1993;549-555.
29. Wright TL, Mamish D, Combs C, Kim M, Donegan E, Ferrell L, Lake J, Roberts J, Ascher NL. Hepatitis B virus and apparent fulminant non-A, non-B hepatitis. Lancet. 339:1992;952-955.
30. Feray C, Samuel D, Gigou M, Paradis V, David MF, Lemonnier C, Reynès M, Bismuth H. An open trial of Interferon alpha Recombinant for hepatitis C after liver transplantation: antiviral effects and risk of rejection. Hepatology. 22:1995;1084-1089.
31. Tur-Kaspa R, Burk RD, Shaul Y, Shafritz DA. Hepatitis B virus DNA contains a glucocorticoid-responsive element. Proc Natl Acad Sci USA. 83:1986;1627-1631.
32. Hoofnagle JH, Dusheiko GM, Schafer DF, Jones EA, Micetich KC. Reactiviation of chronic hepatitis B virus infection by cancer chemotherapy. Ann Intern Med. 96:1982;447-449.